Molecular interactions between soluable host factors and a gene delivery vector
可溶性宿主因子与基因传递载体之间的分子相互作用
基本信息
- 批准号:8583248
- 负责人:
- 金额:$ 26.72万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-10 至 2015-08-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAdenovirus InfectionsAdenovirusesAffinityAntiviral AgentsBindingBloodBlood CirculationBlood Coagulation FactorBody FluidsCAR receptorCapsidCellsClinicComplexCryoelectron MicroscopyDataDefectDevelopmentDouble Stranded DNA VirusEpithelial CellsFactor XFiberGene DeliveryGene Transduction AgentGlutamic AcidHeparan Sulfate ProteoglycanHepatocyteHuman Adenovirus InfectionsHuman AdenovirusesImmune responseInfectionIntegration Host FactorsInterventionIntravenousInvestigationKnowledgeLigand Binding DomainLightLiverLocationMapsMediatingMethodsModelingMolecularMutationPathway interactionsPeptidesPhysiologicalPoint MutationProtease DomainProteinsResolutionRespiratory MucosaSalivaSerine ProteaseStructureSurfaceTropismVaccinesVirusX ray diffraction analysisX-Ray Diffractionbasecarboxylatecell typegene therapyimprovedin vivomutantpublic health relevanceresearch studyrespiratorytissue tropismvectorvector vaccine
项目摘要
DESCRIPTION (provided by applicant): Human adenoviruses (HAdV) are nonenveloped dsDNA viruses that infect a variety of cell types. Species C HAdV5 is the most commonly used vector for gene therapy and vaccine applications in the clinic. Recently, it has been shown that association of species A and C HAdVs with several blood coagulation factors (e.g., Factors X, IX) following intravenous delivery allow these viruses to gain access to epithelial cells and liver
hepatocytes in vivo, respectively. This clotting factor-mediated pathway results in the unintended retargeting of C-type HAdVs to hepatocytes. Remarkably, this retargeting overrides the selectivity of natural receptor (CAR) for the virus fiber protein. Blocking of the hexon-FX interaction, either by pharmacological intervention or mutation of HAd5 hexon protein, abolishes liver transduction in vivo. Although low-resolution structural information on HAdV-FX association is available from cryoEM studies, detailed knowledge on the molecular interactions between the GLA-domain of FX with the hexon on the HAd capsid is still lacking. We recently determined the crystal structure for a HAdV5 based vector, designated Ad35F, at near atomic resolution by X- ray diffraction. Despite this new structural information, we still lack important knowledge of how the virus capsid influences tissue tropism in vivo. The absence of an accurate model of HAdV-FX interactions hampers the development of antivirals and gene therapy vectors. Preliminary diffraction experiments on Ad35F crystals soaked with chemically synthesized GLA (cs-GLA) peptide have been quite positive. Initial Fo-Fc maps at 6¿ resolution indicate that footprint of th GLA domain binding site on the hexon subunits is different from the location previously suggested. This proposal seeks to greatly improve our understanding of adenovirus host cell tropism in vivo by 1) determining the structure of HAdV in complex with the FX-GLA domain at near atomic resolution by employing X-ray diffraction methods. These analyses will build on the extensive knowledge and expertise that we gained in solving the crystal structure of Ad35F at 3.5 ¿ resolution and 2) analyzing the structure of single point mutant (E451Q) in the hexon subunit that drastically reduces FX binding to HAdV suggesting that the region of the hexon containing this mutation is crucial for clotting factor association. We anticipate that these investigations will provide greater understanding of mechanism and underlying molecular interactions involved in adenovirus transduction of liver hepatocytes.
描述(申请人提供):人腺病毒(HAdV)是感染多种细胞类型的无包膜dsDNA病毒。物种C HAdV5是临床上最常用的基因治疗和疫苗应用载体。最近,有研究表明,在静脉注射后,A和C类HAdv与几种凝血因子(如X、IX因子)的结合使这些病毒能够进入上皮细胞和肝脏
活体肝细胞。这种凝血因子介导的途径导致C型HAdv意外地重定向到肝细胞。值得注意的是,这种重定向超越了天然受体(CAR)对病毒纤维蛋白的选择性。通过药物干预或HAd5Hexon蛋白突变来阻断Hexon-FX相互作用,可取消体内的肝转导。尽管HAdV-FX结合的低分辨结构信息可以从低温EM研究中获得,但关于FX的GLA结构域与HAD衣壳上的六邻体之间的分子相互作用仍然缺乏详细的知识。最近,我们用X射线衍射法测定了一种基于HAdV5的载体的晶体结构,命名为Ad35F,具有近原子分辨率。尽管有这些新的结构信息,我们仍然缺乏关于病毒衣壳如何影响体内组织趋向性的重要知识。缺乏准确的HAdV-FX相互作用模型阻碍了抗病毒药物和基因治疗载体的发展。用化学合成的GLA(cs-GLA)多肽对Ad35F晶体进行了初步的衍射实验,得到了相当好的结果。分辨率为6?的初始Fo-Fc图表明,GLA结构域结合位点在六邻体亚基上的足迹与先前提出的位置不同。这一建议旨在通过以下方法极大地提高我们对腺病毒在体内的宿主细胞趋向性的理解:1)利用X射线衍射方法在近原子分辨率下确定HAdV与FX-GLA结构域的复合体的结构。这些分析将建立在我们在解决Ad35F在3.5?分辨率下的晶体结构方面获得的广泛知识和专业知识的基础上,以及2)分析Hexon亚单位中单点突变(E451Q)的结构,该结构极大地减少了FX与HAdV的结合,这表明包含该突变的Hexon区域对于凝血因子关联至关重要。我们期望这些研究将提供更多对腺病毒转导肝细胞的机制和潜在的分子相互作用的理解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
VIJAY S REDDY其他文献
VIJAY S REDDY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('VIJAY S REDDY', 18)}}的其他基金
Structural characterization of nucleoprotein cores of human adenoviruses
人腺病毒核蛋白核心的结构表征
- 批准号:
9807741 - 财政年份:2019
- 资助金额:
$ 26.72万 - 项目类别:
Molecular interactions between soluable host factors and a gene delivery vector
可溶性宿主因子与基因传递载体之间的分子相互作用
- 批准号:
8731791 - 财政年份:2013
- 资助金额:
$ 26.72万 - 项目类别:
ANALYSIS OF PROTEIN-PROTEIN INTERACTIONS AND QUASI-EQUIVALENCE IN VIRUS CAPSIDS
病毒衣壳中蛋白质-蛋白质相互作用和准等价性分析
- 批准号:
7957334 - 财政年份:2009
- 资助金额:
$ 26.72万 - 项目类别:
SEQUENCE-STRUCTURE AND HOMOLOGY MODELING OF ICOSAHEDRAL VIRUS CAPSIDS
二十面体病毒衣壳的序列结构和同源性建模
- 批准号:
7957347 - 财政年份:2009
- 资助金额:
$ 26.72万 - 项目类别:
MODELING VIRUS ASSEMBLY STRUCTURE, ENERGY & THERMODYNAMICS
病毒装配结构、能量建模
- 批准号:
7957333 - 财政年份:2009
- 资助金额:
$ 26.72万 - 项目类别:
X-ray diffraction analysis of human adenoviruses
人腺病毒的 X 射线衍射分析
- 批准号:
8470519 - 财政年份:2008
- 资助金额:
$ 26.72万 - 项目类别:
X-ray Diffraction Analysis of Human Adenovirus
人腺病毒的 X 射线衍射分析
- 批准号:
7689983 - 财政年份:2008
- 资助金额:
$ 26.72万 - 项目类别:
X-ray diffraction analysis of human adenoviruses
人腺病毒的 X 射线衍射分析
- 批准号:
8650773 - 财政年份:2008
- 资助金额:
$ 26.72万 - 项目类别:
X-ray diffraction analysis of human adenoviruses
人腺病毒的 X 射线衍射分析
- 批准号:
8292681 - 财政年份:2008
- 资助金额:
$ 26.72万 - 项目类别:
相似海外基金
RNA interference based therapies for treatment of adenovirus infections in immunosuppressed host
基于 RNA 干扰的疗法用于治疗免疫抑制宿主的腺病毒感染
- 批准号:
211658021 - 财政年份:2012
- 资助金额:
$ 26.72万 - 项目类别:
Research Grants
ASSESSING THE PREVALENCE OF THE BK, CMV, & ADENOVIRUS INFECTIONS IN PED PTS
评估 BK、CMV 的患病率
- 批准号:
7716731 - 财政年份:2008
- 资助金额:
$ 26.72万 - 项目类别:
ASSESSING THE PREVALENCE OF THE BK, CMV, & ADENOVIRUS INFECTIONS IN PED PTS
评估 BK、CMV 的患病率
- 批准号:
7982151 - 财政年份:2008
- 资助金额:
$ 26.72万 - 项目类别:
ASSESSING THE PREVALENCE OF THE BK, CMV, & ADENOVIRUS INFECTIONS IN PED PTS
评估 BK、CMV 的患病率
- 批准号:
7603956 - 财政年份:2006
- 资助金额:
$ 26.72万 - 项目类别:
Immunotherapy of Adenovirus Infections in Stem Cell Transplnt Recipients
干细胞移植受体中腺病毒感染的免疫治疗
- 批准号:
7337161 - 财政年份:2006
- 资助金额:
$ 26.72万 - 项目类别:
Immunotherapy of Adenovirus Infections in Stem Cell Transplant Recipients
干细胞移植受者腺病毒感染的免疫治疗
- 批准号:
7167150 - 财政年份:2006
- 资助金额:
$ 26.72万 - 项目类别:
Immunotherapy of Adenovirus Infections in Stem Cell Transplnt Recipients
干细胞移植受体中腺病毒感染的免疫治疗
- 批准号:
7020895 - 财政年份:2006
- 资助金额:
$ 26.72万 - 项目类别:
Immunotherapy of Adenovirus Infections in Stem Cell Transplnt Recipients
干细胞移植受体中腺病毒感染的免疫治疗
- 批准号:
7545814 - 财政年份:2006
- 资助金额:
$ 26.72万 - 项目类别:
ASSESSING THE PREVALENCE OF THE BK, CMV, & ADENOVIRUS INFECTIONS IN PED PTS
评估 BK、CMV 的患病率
- 批准号:
7368241 - 财政年份:2005
- 资助金额:
$ 26.72万 - 项目类别:
National Surveillance for Emerging Adenovirus Infections
新发腺病毒感染的国家监测
- 批准号:
6899378 - 财政年份:2004
- 资助金额:
$ 26.72万 - 项目类别: